USPTO Biotechnology, Chemical, and Pharmaceutical Customer Partnership Meeting June 30, 2016 Stakeholder’s Perspective on Patent Quality Initiative Frank.

Slides:



Advertisements
Similar presentations
Prosecution Lunch Patent January Extended Missing Parts Pilot Program Requirements –A non-provisional meeting filing-date standards and claiming.
Advertisements

Technology Center 1600 Training on Writing Rejections Under 35 U.S.C. § 103.
Managing Intellectual Property Assets in International Business Anil Sinha, Counsellor, SMEs Division World Intellectual Property Organization (WIPO)
MELISSA ASFAHANI Patent Attorney El Paso, TX
Michael P. Woodward Supervisory Patent Examiner, Art Unit 1631 (703) Bioinformatics & §101
INTELLECTUAL PROPERTY PROTECTION OFFICE OF PATENT COUNSEL March 16, 2001.
1 TC1600-Quality Assurance Bennett Celsa QAS Joseph Woitach SPE June 4, 2013.
Bicoastal Biotechnology/Chemical/Pharmaceutical Customer Partnership Meeting RCE Progress Update Daniel Sullivan Director, TC1600 September 17, 2014.
1 1 1 AIPLA American Intellectual Property Law Association USPTO Updates Including Glossary Pilot Program Chris Fildes Fildes & Outland, P.C. IP Practice.
PROSECUTION APPEALS Presented at: Webb & Co. Rehovot, Israel Date: February 14, 2013 Presented by: Roy D. Gross Associate St. Onge Steward Johnston & Reens.
1 1 AIPLA American Intellectual Property Law Association RCE Practice: Pilot Programs and Delays in Examination Chris Fildes Fildes & Outland, P.C. IP.
September 14, U.S.C. 103(c) as Amended by the Cooperative Research and Technology Enhancement (CREATE) Act (Public Law ) Enacted December.
America Invents Act (AIA) Changes in Patent Law That Impact Companies May Mowzoon: Mowzoon Law Office, PLLC 1.
Accelerated Examination Bennett Celsa (TC 1600: QAS)
by Eugene Li Summary of Part 3 – Chapters 8, 9, and 10
Patent Quality Assurance Program. 2 Office of Patent Quality Assurance (OPQA) Deputy Commissioner for Patent Operations Office of Patent Quality Assurance.
Intellectual Property Patent Primer Michael Pratt Executive Director, Business Development November 1, 2011.
Information Disclosure Statements
Chinese Utility Model and Design Patents as Shields … and Swords Chinese Utility Model and Design Patents as Shields … and Swords Managing Intellectual.
December 8, Changes to Patent Fees Under the Consolidated Appropriations Act, 2005 (H.R. 4818)(upon enactment) and 35 U.S.C. 103(c) as Amended by.
Utility Requirement in Japan Makoto Ono, Ph.D. Anderson, Mori & Tomotsune Website:
The New USPTO Rules and their Impact on Biomedical Patent Prosecution Mojdeh Bahar, J.D.,M.A. Technology Licensing Specialist Office of Technology Transfer.
New York | London | Munich | Sydney | Tokyo Cost-Effective International Patenting Strategies: Expand Your Global Opportunity Presented by Jeff Sweetman.
2 23,503 hours in FY 2013, compared with 21,273 hours in FY ,651 interview hours in FY 13 have been charged through the AFCP program. Interview.
35 USC 101 Update Business Methods Partnership Meeting, Spring 2008 by Robert Weinhardt Business Practice Specialist, Technology Center 3600
Overview OTL Mission Inventor Responsibility Stanford Royalty Sharing Disclosure Form Patent View Inventor Agreements Patent.
1 Patent Quality Initiatives Biotechnology/Chemical/Pharmaceutical Customer Partnership Tuesday, April 7, 2015 Valencia Martin-Wallace Deputy Commissioner.
1 Patent Law in the Age of IoT The Landscape Has Shifted. Are You Prepared? 1 Jeffrey A. Miller, Esq.
Technology Transfer Practice Ken Porter Steamboat Mountain Solutions copyright 2011 all rights reserved.
 Being the new reimbursement manager, I hope to work with you all for the benefit of this entity.  I manage reimbursement transactions, as well as facilitating.
July 18, U.S.C. 103(c) as Amended by the Cooperative Research and Technology Enhancement (CREATE) Act (Public Law ) Enacted December 10,
After Final Practice Linda M. Saltiel June 2, 2015.
6.1 Chapter 6 Patents © 2003 by West Legal Studies in Business/A Division of Thomson Learning.
Advanced Legal Writing Seminar: Wednesdays, 10:00 p.m. EST Office Hours: Mondays from 3 – 5 p.m. EST, and by appointment AIM sign-in: cssouthall
QualityDefinition.PPACMeeting AdlerDraft 1 1 Improving the Quality of Patents Marc Adler PPAC meeting June 18, 2009.
Staffing and training. Objectives To understand approaches to the development of strategies and policies for staffing of a Regulatory Authority including.
Chris Fildes FILDES & OUTLAND, P.C. IP Practice in Japan Committee Pre-Meeting AIPLA Annual Meeting, October 20, 2015 USPTO PILOT PROGRAMS 1 © AIPLA 2015.
Prosecution Luncheon Patent October PDF’s Now Available on USPTO Website.
1 Patent Prosecution: Best Practices for Reducing Costs While Improving Patent Quality February 9, 2010.
Claims and Determining Scope of Protection -Introduction Nov. 9, 2014 APAA Patents Committee Penang Malaysia Kay Konishi Co-chair of APAA Patents Committee.
Copyright © 2015 Oblon, McClelland, Maier & Neustadt, LLP Inside the USPTO Peggy Focarino Senior Patent Advisor.
Patents and the Patenting Process Patents and the Inventor’s role in the Patenting Process.
Careers in Patent Law Jeffrey Sunman, Ph.D. Patent Agent Daniel O’Brien, Ph.D. Patent Attorney Alston and Bird LLP.
Charles University – Law Faculty October 2012 © Peter Kolker 2012 Class III
The Applicability of Patent-Agent Privilege After In re Queen’s University at Kingston Presented by Rachel Perry © 2016 Workman Nydegger.
Technology Transfer Office
Patents Amy Bilton Knowledge Transfer Officer.
The Challenge of Biotech Patent Eligibility in the United States:
Managing Intellectual Property Assets in International Business
PRE-SUIT CONSIDERATIONS
The scope and focus of the Research
Locating The Problem Dr. Anshul Singh Thapa.
WEEK 1 – RESEARCH PROPOSAL
Research Methods RESEARCH PROPOSAL.
United States - Software
Options to Protect an Invention: the Patent Cooperation Treaty (PCT) and Trade Secrets Hanoi October 24, 2017 Peter Willimott Senior Program Officer WIPO.
Of Counsel Polsinelli, LLP
The Role of Patent Attorneys
Accelerating your Patent Prosecution in Mexico
Maximize Your TTO’s Patent Budget
Nuts and Bolts of Patent Law
Youngwummin: Ethics and Data Collection Methods
Sacramento City Unified School District V. Rachel H U. S
Preparing a Case Brief.
Jackie Hutter, MS, JD What Innovators Need to Know about IP Protection: A Business-Focused Approach Jackie Hutter, MS, JD
The National Association of Patent Practitioners (NAPP)
Tribal Court Family Code Development: A Practical Guide
Boston Patent Law Association Annual Meeting
Jonathan D’Silva MMI Intellectual Property 900 State Street, Suite 301
Presentation transcript:

USPTO Biotechnology, Chemical, and Pharmaceutical Customer Partnership Meeting June 30, 2016 Stakeholder’s Perspective on Patent Quality Initiative Frank Grassler, J.D. VP For Technology Development

Who Are We? UT Southwestern is a world class medical university engaged in biomedical education, research, development, and patient care Our 2,100 faculty generate an average of 160 new biomedical inventions per year, operating under a research budget of about $430M per year

What’s Our Role in the Patent System? The Office for Technology Development manages the University’s inventions, patents, product development, licenses, and start-up formation After evaluating an invention disclosure received from our faculty, we decide on the most sensible course of action

How We Pursue Invention Protection If we decide to file a patent application, we file a US provisional application We don’t draft applications in-house, we rely on outside patent attorneys If we license an invention, the licensee takes over responsibility for the rest of the prosecution, domestic and foreign

What Matters To Us Cost – Attorney’s Professional Fees – Application Filing Fees – Time spent on the matter-this is where the USPTO’s quality initiatives impact us the most Defensibility/Enforceability

EPQI Programs Considered Search And Training Enhancement Programs – Automated Pre-Examination Search Pilot – Scientific and Technical Information Center Awareness Campaign – Clarity of Record Training Prosecution Enhancement Programs – Quality of Record Pilot – Interview Specialist – Reevaluation of After-Final Consideration Pilot Post-examination Enhancement Programs – Design Patent Publication Quality – Post Grant Outcomes Evaluation Enhancement Programs – Clarity and Correctness Data Capture – Quality Metrics – Topic Submission For Case Studies

General Observations Appreciation that metrics have been selected and are being gathered and analyzed Positive impression from the number of initiatives created

Other Useful Programs Programs used most often: – (1) After Final Consideration Pilot 2.0; – (2) the pre-appeal brief; and – (3) the QuickPath Information Disclosure Statement (QPIDS). These 3 programs have greatly reduced the cost to the client, generally improved the communication between examiner and attorney, and streamlined the prosecution process (the QPIDS is great when there is foreign prosecution-greatly aids the attorney they keep getting more references from foreign prosecution that we must cite to the USPTO). Programs are good-continue them.

Subject Matter Eligibility Examples (& 2014 Interim Guidance on Subject Matter Eligibility) Guidelines do not appear to align with relevant case law, especially in view of the Supreme Court’s refusal to grant cert in the case of Sequenom v. Ariosa – Net effect is that attorneys must advise clients that two inconsistent outcomes are possible, i.e. pursue allowable claims vs. obtain enforceable claims

Subject Matter Eligibility Examples (& 2014 Interim Guidance on Subject Matter Eligibility) In all fairness, we recognize that the USPTO is confronted with a lack of clarity in the case law Continued uncertainty from the courts is expected ‘It’s a huge mess”

Eligibility Examples Examples would benefit from avoiding unduly narrow fact patterns, which are seen to lead Examiners to perform excessively rigid examinations – E.g. Example 28, cl.7: the microneedle array that forms part of the claim limits the scope of the claim so severely that the usefulness of the example is diminished It is a relief to see examples to diagnostics- possible path back to diagnostic patents again

Eligibility Examples An inconsistency in the examples: Example 29 claim 1 vs claim 2 – Why does the addition of a limitation on “diagnosing” render cl. 2 eligible, compared to cl. 1 ? – It is not doctrinally sound to take an ineligible claim and make it eligible through the addition of a limitation, since limitations determine patentability over prior art

Another Metric to Consider “I really think what is missing is more training and quality control of the supervisory examiners. We still get huge variability between examiners and sometimes it seems there is no supervision whatsoever. We have had a few cases where the examiner did not even have a supervisor for 6 months! So, the time taken to fill vacancies for supervisors and training of supervisors would seem to be another metric the PTO should look into measuring.”

Here’s an Idea: “In my practice, I have found that having lunch on a frequent basis with a current patent examiner (who happens to live in Dallas, and before whom we do NOT practice as we don’t have any cases in his art unit) has been (very) helpful. We tend to get a preview for what initiatives supervisory examiners are going to start pushing forward, the type of training the examiners are getting, the pressure they are under, we get great tips about how an examiner views the art and claims, and get explanations for actions from the PTO that do not otherwise make sense! Not sure the PTO has a pilot program for his, but its made a positive difference in how we practice in our office.”

By The Way… The Formalities process has really improved with a definite decrease in the extent seen of the human error problems